Health Insurance Innovations, Inc. (HIIQ)
(Delayed Data from NSDQ)
$23.76 USD
+2.20 (10.20%)
Updated May 3, 2019 04:00 PM ET
After-Market: $23.98 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$23.76 USD
+2.20 (10.20%)
Updated May 3, 2019 04:00 PM ET
After-Market: $23.98 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Should Value Investors Pick Health Insurance (HIIQ) Stock?
by Zacks Equity Research
Let's see if Health Insurance (HIIQ) stock is a good choice for value-oriented investors right now from multiple angles.
Is the Options Market Predicting a Spike in Health Insurance Innovations (HIIQ) Stock?
by Zacks Equity Research
Investors need to pay close attention to Health Insurance Innovations (HIIQ) stock based on the movements in the options market lately.
The Zacks Analyst Blog Highlights: Limbach, Health Insurance, Fibrocell, Camden and First Business
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Limbach, Health Insurance, Fibrocell, Camden and First Business
Small Business Optimism Hits 4-Month High in April: 5 Picks
by Nalak Das
Small corporates create significant amount of jobs in the U.S. economy.
The Zacks Analyst Blog Highlights: eGain, Enova, Everi, Limbach and Health Insurance Innovations
by Zacks Equity Research
The Zacks Analyst Blog Highlights: eGain, Enova, Everi, Limbach and Health Insurance Innovations
5 Top Small-Cap Picks to Shrug Off Lingering Trade Tensions
by Nalak Das
Re-escalation of Trump-imposed tariffs are likely to significantly disrupt the global supply chain system and halt economic activities worldwide.
New Strong Buy Stocks for May 10th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Top Ranked Value Stocks to Buy for May 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 10th.
Top Ranked Value Stocks to Buy for May 8th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 8th.
Implied Volatility Surging for Health Insurance Innovations (HIIQ) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Health Insurance Innovations (HIIQ) stock based on the movements in the options market lately.
Health Insurance Innovations (HIIQ) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Health Insurance Innovations (HIIQ) delivered earnings and revenue surprises of -12.24% and -2.83%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Top Ranked Value Stocks to Buy for May 6th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 6th.
What Awaits Health Insurance Innovations (HIIQ) in Q1 Earnings?
by Tanuka De
Health Insurance Innovations' first-quarter results are likely to benefit from its compelling portfolio of core products and individual and family plans.
Are Investors Undervaluing Health Insurance Innovations (HIIQ) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Health Insurance Innovations (HIIQ) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Health Insurance Innovations (HIIQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Advanced Emissions, Aptevo, BankFinancial, Good Times and Health Insurance
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Advanced Emissions, Aptevo, BankFinancial, Good Times and Health Insurance
5 Stocks to Gain From Dollar's Recent Strength
by Tirthankar Chakraborty
The U.S. dollar hits an almost 2-year record high as global central banks turn dovish and German business moral deteriorates.
Top Ranked Value Stocks to Buy for April 26th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 26th.
Health Insurance Innovations (HIIQ) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Health Insurance Innovations (HIIQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Health Insurance Innovations (HIIQ) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Health Insurance Innovations (HIIQ) closed at $24 in the latest trading session, marking a -0.83% move from the prior day.
Top Ranked Value Stocks to Buy for April 17th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 17th
Can Health Insurance Innovations (HIIQ) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Health Insurance Innovations (HIIQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is Why Growth Investors Should Buy Health Insurance Innovations (HIIQ) Now
by Zacks Equity Research
Health Insurance Innovations (HIIQ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Voya Financial & Units Get Rating Affirmation from A.M. Best
by Tanuka De
Voya Financial (VOYA) and units' rating are reiterated given strong balance sheet, operational excellence and effective enterprise risk management.
Here's Why You Should Add Reinsurance Group to Your Portfolio
by Zacks Equity Research
Reinsurance Group (RGA) rides on operational excellence and promises better rewards for investors.